Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayoshi Harigai

Showing results (31-40 of 309) with videos related to

Pageof 31
Sort By:
The Journal of Rheumatology|April 17, 2017
Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort StudySayoko Harada, Ryoko Sakai, Fumio Hirano, et al.
Journal of Bone and Mineral Metabolism|April 6, 2025
Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohortTakefumi Furuya, Eisuke Inoue, Hisashi Yamanaka, et al.
Immunology Letters|August 8, 2025
A shared monocyte cytokine signature induced by serum from patients with systemic lupus erythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathwayShohei Nakamura, Yuko Okamoto, Hideto Takada, et al.
Modern Rheumatology|September 29, 2020
Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective studyYuko Okamoto, Yasuhiro Katsumata, Sayumi Baba, et al.
JMA Journal|December 16, 2020
Management of End-stage Renal Disease Associated with Systemic Rheumatic DiseasesSuguru Honda, Yasuhiro Katsumata, Kazunori Karasawa, et al.
Modern Rheumatology|October 10, 2006
Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapyJun Ogawa, Masayoshi Harigai, Kenji Nagasaka, et al.
Rheumatology (Oxford, England)|October 11, 2022
Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical applicationSuguru Honda, Koichiro Yano, Eiichi Tanaka, et al.
Modern Rheumatology|September 3, 2022
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge studyMasayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, et al.
The Journal of Rheumatology|February 13, 2002
Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatmentEiichi Tanaka, Masayoshi Harigai, Michi Tanaka, et al.
International Journal of Rheumatic Diseases|March 8, 2020
Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severityKae Takagi, Manabu Kawamoto, Tomoaki Higuchi, et al.
Pageof 31

Showing results (31-40 of 309) with videos related to

Sort By:
Pageof 31
The Journal of Rheumatology|April 17, 2017
Association Between Medications and Herpes Zoster in Japanese Patients with Rheumatoid Arthritis: A 5-year Prospective Cohort StudySayoko Harada, Ryoko Sakai, Fumio Hirano, et al.
Journal of Bone and Mineral Metabolism|April 6, 2025
Increasing fracture incidence over 13 years in patients with rheumatoid arthritis from the IORRA cohortTakefumi Furuya, Eisuke Inoue, Hisashi Yamanaka, et al.
Immunology Letters|August 8, 2025
A shared monocyte cytokine signature induced by serum from patients with systemic lupus erythematosus and anti-MDA5 antibody-positive dermatomyositis through the type I interferon pathwayShohei Nakamura, Yuko Okamoto, Hideto Takada, et al.
Modern Rheumatology|September 29, 2020
Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective studyYuko Okamoto, Yasuhiro Katsumata, Sayumi Baba, et al.
JMA Journal|December 16, 2020
Management of End-stage Renal Disease Associated with Systemic Rheumatic DiseasesSuguru Honda, Yasuhiro Katsumata, Kazunori Karasawa, et al.
Modern Rheumatology|October 10, 2006
Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapyJun Ogawa, Masayoshi Harigai, Kenji Nagasaka, et al.
Rheumatology (Oxford, England)|October 11, 2022
Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical applicationSuguru Honda, Koichiro Yano, Eiichi Tanaka, et al.
Modern Rheumatology|September 3, 2022
A multicentre, large-scale, observational study of tocilizumab in patients with Takayasu arteritis in Japan: The ACTEMRA® (ACT)-Bridge studyMasayoshi Harigai, Takako Miyamae, Hideyuki Hashimoto, et al.
The Journal of Rheumatology|February 13, 2002
Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatmentEiichi Tanaka, Masayoshi Harigai, Michi Tanaka, et al.
International Journal of Rheumatic Diseases|March 8, 2020
Single nucleotide polymorphisms of the HIF1A gene are associated with susceptibility to pulmonary arterial hypertension in systemic sclerosis and contribute to SSc-PAH disease severityKae Takagi, Manabu Kawamoto, Tomoaki Higuchi, et al.
Pageof 31